Mitochondria in Motion, Inc

Capybio LLC is a company based in St. Louis, MO, specializing in providing innovative solutions in the field of biotechnology. They focus on developing cutting-edge products and services to address various challenges in the industry. With a commitment to research and development, Capybio LLC aims to contribute to advancements in biotechnology through their unique approach and expertise. Their team of professionals work diligently to deliver high-quality solutions that meet the needs of their clients and partners. Generated from their business information

BioGenerator Ventures is a St. Louis-based investment firm that specializes in creating, building, and investing in companies that address critical challenges in human health and agriculture. With a portfolio spanning various sectors within the life sciences, including therapeutics, diagnostics, medical devices, research tools, agriculture, and healthcare, BioGenerator Ventures has invested $39 million into startups and has helped its portfolio companies raise over $2.6 billion in funding. Through its BioGenerator Labs engine, BioGenerator Ventures provides catalytic investments to life sciences companies, offering a suite of resources such as technology, talent, proof of concept grants, coaching, grant training, and innovative laboratory space to accelerate the growth of new ventures. With a track record of successful exits and partnerships, BioGenerator Ventures has played a crucial role in the development and maturation of companies like Geneoscopy, Medibeacon, and Benson Hill, helping them achieve significant milestones and become venture-funded and revenue-generating entities.Generated from the website

Immunophotonics, Inc. is a pioneering biotechnology company based in Saint Louis, MO, dedicated to unlocking the potential of the immune system through the development of a new class of therapeutics. Their proprietary glycan polymer technology stimulates antigen capture and uptake, triggering an immune response that enables the rejection of cancer and other diseases. With practical applications in interventional oncology, immunotherapy, and vaccine enhancement, Immunophotonics aims to elevate modern medicine and improve outcomes for patients worldwide. Through their innovative approach, Immunophotonics is transforming conventional surgical interventions into systemically active immunotherapies, upregulating T-cell activation, downregulating T-cell exhaustion, and driving stronger immune responses. Their powerful immunoadjuvant, IP-001, has the potential to enhance antigen-specific immunity against infectious diseases, including SARS-CoV-2, and increase the efficacy of vaccines. Committed to global human health, Immunophotonics is at the forefront of advancing medical treatments and improving patient outcomes.Generated from the website